about
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...
Read More
14.20
-0.19
(-1.32%)
2,052.5
XNAS Volume
XNAS 23 Jul, 2026 9:32 AM (EDT)
Board Meeting
The board meeting for Polyrizon Ltd is scheduled for today, for the purpose of Polyrizon Ltd First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Polyrizon Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..